Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients
NCT05696977Phase 4Recruiting
- Sponsor
- Alexandria University
- Start
- Apr 2022
- Primary completion
- Feb 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine in nephrotic syndrome, sponsored by Alexandria University. Started Apr 2022; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT05696977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05696977.